Integrated multi-dimensional deep neural network model improves prognosis prediction of advanced NSCLC patients receiving bevacizumab

BACKGROUND: The addition of bevacizumab was found to be associated with prolonged survival whether in combination with chemotherapy, tyrosine kinase inhibitors or immune checkpoint inhibitors in the treatment landscape of advanced non-small cell lung cancer (NSCLC) patients. However, the biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Butuo, Yang, Linlin, Jiang, Chao, Yao, Yueyuan, Li, Haoqian, Cheng, Shuping, Zou, Bing, Fan, Bingjie, Wang, Linlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972089/
https://www.ncbi.nlm.nih.gov/pubmed/36865790
http://dx.doi.org/10.3389/fonc.2023.1052147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972089/
https://www.ncbi.nlm.nih.gov/pubmed/36865790
http://dx.doi.org/10.3389/fonc.2023.1052147

Ejemplares similares